In comparison between thyroid cancer and peritumoral tissues, the expression levels of PTCSC3 were reduced significantly in all stages but there was no significant difference in PTCSC3 expression between clinical stages (I, II, III, IV), suggesting that PTCSC3 downregulation is an early event in PTC progression [18]. This evidence concerns the gene PTCSC3 and thyroid gland carcinoma.